RBR-2c3t8gb进行中(未招募)2 期
Metformin gel in the Periodontal treatment of patients people with type II Diabetes Mellitus with Periodontitis
Centro de Ciências Biológicas e da Saúde CCBS - Universidade Estadual do Oeste do Paraná0 个研究点开始时间: 2023年11月2日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 进行中(未招募)
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18Y 至 70Y(—)
入选标准
- •Patients of both sexes with Periodontitis stages 1, 2, 3 or 4, grade B or C, presenting bleeding on probing and gingival inflammation. Patients must have the pathophysiological condition of Type II Diabetes Mellitus (diagnosed by endocrinologists) and use systemic Metformin. Patients who agree to participate in the study, signing the informed consent form. Patient aged between 18 and 70 years
排除标准
- •Patients with a positive history in the last 6 months of broad-spectrum antibiotic therapy, steroidal anti-inflammatory drugs or immunosuppressive therapy in the 3 months prior to the study. Pregnant or lactating. History of periodontal treatment in the last 6 months. Smoking or quitting the habit for less than 5 months. Patients who have less than 4 teeth or have misaligned teeth in the dental arch. Patient under 18 years old or over 70 years old
研究者
相似试验
尚未招募
3 期
Evaluation of metformin gel effect on prevention of radiation acute dermatitisIRCT20211029052907N3Zanjan University of Medical Sciences52
已完成
2 期
1% Metformin in Moderate and Severe PeriodontitisPeriodontitisNCT02274090Government Dental College and Research Institute, Bangalore70
尚未招募
2 期
This is a clinico-radiographic study to compare and evaluate the efficacy of 1% Metformin (MF) gel in combination with Platelet Rich fibrin and Platelet Rich Fibrin (PRF) alone in the treatment of Class II furcation defects.CTRI/2019/03/018282Self
已完成
不适用
EFFECT OF 1% METFORMIN GEL ON BONECTRI/2021/07/035169k Govardhani18
尚未招募
不适用
Phase II study of oral metformin for intravesical treatment of non- muscle-invasive bladder cancer (TROJAN)NL-OMON25176Amsterdam UMC, AMC49
